ディメンショナル・プライミングは,脂質由来ストロマル細胞を再プログラムして,臓がんの進行を促進します
Bo Han1,2, Zhi Yang1, Shuqing Zhao1
1Departments of Surgery, University of Southern California, Los Angeles, CA 90033, USA.
Cancers
|February 13, 2026
まとめ
脂肪系由来ストロマル細胞 (ADSC) の次元プライミングは,3D培養が臓管状腺がん (PDAC) の成長と侵入を促進し,2D培養がそれを抑制するとは異なり,3D培養は脂肪系由来ストロマル細胞 (ADSC) の行動を大幅に変化させます. これは,PDAC腫瘍マイクロ環境における重要なレギュレータとしての機械的シグナルを強調しています.
科学分野:
- 癌生物学 癌生物学について
- バイオマテリアル科学 バイオマテリアル科学
- 免疫学 免疫学とは
背景:
- 腫瘍の微小環境 (TME) は,臓管腺がん (PDAC) の進行において極めて重要です.
- TMEにおけるストロマル細胞の行動に影響を与える機械的なシグナルについては,十分に理解されていません.
研究 の 目的:
- 脂肪系由来ストロマル細胞 (ADSCs) の次元プライミングが,それらの免疫調節機能にどのように影響するかを調査する.
- PDACの成長に対する次元プライミングの影響を判断する.
主な方法:
- ADSCは2Dおよび3D条件で培養されました.
- PDACオルガノイドとインビトロ共培養とインビボ異種移植モデルを使用した.
- ストロマル現象型,サイトカイン分泌,腫瘍の成長,侵入,免疫細胞の浸透を評価した.
主要な成果:
- 3DプリミングされたADSCは,CAV-1が減少したCAFのようなフェノタイプを採用し,溶解因子 (IL-6,TNF-α) を介してPDACの移行と成長を促進しました.
- 2DプライムされたADSCsは,PDACの成長と侵入を in vitroと in vivoで抑制し,腫瘍の境界を維持しました.
- 3DプライムされたADSCsは,攻撃的な侵入でより大きな腫瘍につながり,2DプライムされたADSCsは,成長を抑制し,2Dプライムされた腫瘍ではマクロファージの浸透が最も高かった.
結論:
- 次元プライミングは,ADSCのフェノタイプとストロマル-免疫相互作用を根本的に再プログラムします.
- この再プログラミングは,PDACの進行を加速する腫瘍許容状態を生成します.
- 機械的なシグナルは,PDACマイクロ環境内のストロマの可塑性の重要な調節因子である.
関連する概念動画
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
01:29Somatic to iPS Cell Reprogramming
2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
02:40The Eukaryotic Promoter Region
19.0K
The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences. The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
19.0K
02:40The Eukaryotic Promoter Region
4.0K
4.0K
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
01:14Introduction to Nuclear Reprogramming
2.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K